Skip to search formSkip to main contentSkip to account menu

RS 2135

Known as: RS-2135 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

CarbazolesIsoquinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Effects of RS‐2135, a Novel Class I Antiarrhythmic Agent, on Sustained Ventricular Tachycardia After Coronary Embolization in Conscious Dogs
To assess the ability of RS-2135, a novel class I antiarrhythmic agent to suppress ischemia-induced ventricular arrhythmias, we… 
1993
1993
Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide‐sensitive K+ currents in Xenopus oocytes
1 The novel K+ channel opener, Y‐26763 induced outward K+ currents in voltage‐clamped follicle‐enclosed Xenopus oocytes in a… 
1993
1993
Effects of RS‐2135, a New Antiarrhythmic Agent, on the Kinetics of Use‐Dependent Decrease in Maximum Upstroke Velocity in Guinea Pig Ventricular Myocardium
The use-dependent decrease in maximum upstroke velocity (Vmax) caused by RS-2135, a new antiarrhythmic compound was analyzed in… 
1992
1992
Electrophysiologic Effects of RS-2135, a New Antiarrhythmic Compound, on Canine Purkinje Fibers
Summary: RS-2135 is the (+) isomer of a novel, fused carbazol derivative. The agent, when administered orally, shows long-lasting… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)